Skip to content

Basket

You currently have no items in your basket.

Total (excl. vat) £0.00
View basket & checkout
Antibodies

AF/LE Purified Anti-Human IL-9 Antibody[MH9A4]

Product Sizes
25 ug
£66.00
AN007820-25UG
100 ug
£89.00
AN007820-100UG
1 mg
£171.00
AN007820-1MG
5 mg
£490.00
AN007820-5MG
25 mg
£1515.00
AN007820-25MG
50 mg
£2247.00
AN007820-50MG
100 mg
£3211.00
AN007820-100MG
About this Product
SKU:
AN007820
Additional Names:
Cytokine P;Interleukin;TCGF;IL9;HP40;IL-9;P40;Cytokine P40;Interleukin-9;P40 Cytokine;P40 T-cell and Mast Cell Growth Factor;T-cell Growth Factor P40;TCGF3;TCGFIII
Application:
Flow Cytometry
Buffer:
Sterile PBS, pH 7.2. < 1.0 EU per mg of the antibody as determined by the LAL method.
translate.label.attr.clone:
MH9A4
Clonality:
Monoclonal
Concentration:
>= 1 mg/ml
Extra Details:
IL-9 is a 14 kDa cytokine originally named P40 and identified by its proliferative effects on T cell populations. The receptor, which is a heterodimer of the gamma chain portion of the IL-2 receptor and the IL-9R chain, activates Jak/STAT signaling pathways upon binding its ligand. Since the discovery of IL-9, numerous other functions have been observed. It induces Th17 and Treg differentiation in CD4+ T cells, IgE production in B cells, and the differentiation and proliferation of mast cells. IL-9 expression was initially observed in Th2 cells, but has since been found in Th17, eosinophil, and mast cells. Th9 cells, a newly discovered subset of CD4+ T cells, are characterized by the secretion of large amounts of IL-9 and IL-10. Th9 development is induced by stimulation of undifferentiated CD4+ with IL-4 and TGF beta. Th2 cells can also be driven towards a Th9 phenotype in the presence of TGF beta.
Host:
Mouse
Immunogen:
IL-9|Recombinant Human IL-9 protein
Isotype:
IgG2b, kappa
Purity:
>98%
Purification:
protein a/g purified
Reactivities:
Human
Shipping Conditions:
Blue Ice
Storage Conditions:
2-8[o]C Avoid freeze/thaw cycles., -20[o]C Avoid freeze/thaw cycles.
Supplier:
Elabscience
Type:
Antibody: Monoclonal Antibody
Mouse peritoneal macrophages were stained with 0.2 ug Purified Anti-Mouse CD115 Antibody[AFS98](Right) and 0.2 ug Rat IgG2a, K Kappa Isotype Control(Left), followed by APC-conjugated Goat Anti-Rat IgG Secondary Antibody.
Human peripheral blood lymphocytes were stained with 0.2 ug Purified Anti-Human CD4 Antibody[RPA-T4](Right) and 0.2 ug Mouse IgG1, K Kappa Isotype Control(Left), followed by PE-conjugated Goat Anti-Mouse IgG Secondary Antibody.
Human peripheral blood lymphocytes were stained with 0.2 ug AF/LE Purified Anti-Human CD4 Antibody[RPA-T4] (Right) and 0.2 ug Mouse IgG1, K Kappa Isotype Control (Left), followed by PE-conjugated Goat Anti-Mouse IgG Secondary Antibody.
Human peripheral blood lymphocytes were stained with 0.2 ug AF/LE Purified Anti-Human CD8a Antibody[OKT-8] (Right) and 0.2 ug Mouse IgG2a, K Kappa Isotype Control (Left), followed by Elab Fluor® 647-conjugated Goat Anti-Mouse IgG Secondary Antibody.
C57BL/6 Mouse bone marrow cells were stained with 0.2 ug AF/LE Purified Anti-Mouse Ly6G Antibody[1A8] (Right) and 0.2 ug Rat IgG2a, K Kappa Isotype Control (Left), followed by Elab Fluor® 647-conjugated Goat Anti-Rat IgG Secondary Antibody.